secwatch.observer — SEC 8-K summary
======================================

Issuer:     Larimar Therapeutics, Inc. (LRMR)
CIK:        0001374690
Form:       8-K
Filed at:   2024-11-18T23:59:59+00:00
Accession:  0000950170-24-127768
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Larimar Therapeutics posts corporate slide presentation; no material facts visible from truncated exhibit
--------------------------------------------------------------------------------

- Filed 8-K on Nov 18, 2024, attaching a corporate presentation (Exhibit 99.1).
- Presentation content not fully available; only header 'November 2024 Larimar Therapeutics Corporate Deck' shown.
- Presentation will be used in investor and analyst meetings, but no specific updates disclosed in filing.
- Unable to extract numerical targets, pipeline milestones, or financial guidance from the provided text.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1374690/000095017024127768/0000950170-24-127768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1374690/000095017024127768/lrmr-20241118.htm
  HTML page:      https://secwatch.observer/filing/0000950170-24-127768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer